Crystalline forms of venlafaxine hydrochloride

Details for Australian Patent Application No. 2002212340 (hide)

Owner Sandoz AG

Inventors Szelagiewicz, Martin; Van Der Schaaf, Paul Adriaan; Freiermuth, Beat; Marcolli, Claudia

Agent Spruson & Ferguson

Pub. Number AU-B-2002212340

PCT Pub. Number WO02/36542

Priority 00811014 31.10.00 EP

Filing date 23 October 2001

Wipo publication date 15 May 2002

Acceptance publication date 14 December 2006

International Classifications

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 213/08 (2006.01) Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton

C07C 213/10 (2006.01) Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton

C07C 217/74 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

Event Publications

27 July 2006 Assignment before Grant

  Ciba Specialty Chemicals Holding Inc. The application has been assigned to Sandoz AG

14 December 2006 Application Accepted

  Published as AU-B-2002212340

19 April 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002212341

2002212339-SOUND-PROOF COMPOSITE SYSTEM FOR SPACE LIMITING SURFACES